Real-World Outcomes of Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Pulmonary Disease

被引:3
|
作者
Kim, Bo-Guen [1 ]
Kim, Sae Rom [2 ]
Jhun, Byung Woo [3 ]
机构
[1] Hanyang Univ, Coll Med, Dept Internal Med, Div Pulm Med & Allergy, Seoul, South Korea
[2] Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Coll Med, Dept Pulm & Crit Care Med, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, 81 Irwon Ro, Seoul 06351, South Korea
关键词
LUNG-DISEASE;
D O I
10.4046/trd.2023.0120
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:202 / 205
页数:4
相关论文
共 50 条
  • [21] A Retrospective Analysis to Assess the Discontinuation of Amikacin Liposome Inhalation Suspension Therapy Among Patients Treated for Refractory Mycobacterium Avium Complex Lung Disease
    Puc, M.
    Koerner, P.
    Russian, A.
    Faris, R.
    Vanscoy, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [22] Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Mycobacterium Avium Complex (MAC) Lung Disease: Effect of Baseline Amikacin and Clarithromycin Susceptibility on Culture Conversion
    Winthrop, K. L.
    Flume, P. A.
    Thomson, R.
    Brown-Elliott, B. A.
    Wallace, R. J., Jr.
    Griffith, D. E.
    Pennings, L. J.
    Coulter, C.
    Syrmis, M.
    Pandey, S.
    Yuen, D.
    Mange, K.
    van Ingen, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [23] Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease (vol 79, pg 555, 2019)
    Shirley, Matt
    DRUGS, 2019, 79 (07) : 791 - 791
  • [24] Amikacin liposome inhalation suspension for Mycobacterium avium complex pulmonary disease: A subgroup analysis of Japanese patients in the randomized, phase 3, CONVERT study
    Morimoto, Kozo
    Nonaka, Mizu
    Yamazaki, Yoshitaka
    Nakagawa, Taku
    Takasaki, Jin
    Tsuyuguchi, Kazunari
    Kitada, Seigo
    Jumadilova, Zhanna
    Yuen, Dayton W.
    Ciesielska, Monika
    Hasegawa, Naoki
    RESPIRATORY INVESTIGATION, 2024, 62 (02) : 284 - 290
  • [25] Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure
    Griffith, David E.
    Thomson, Rachel
    Flume, Patrick A.
    Aksamit, Timothy R.
    Field, Stephen K.
    Addrizzo-Harris, Doreen J.
    Morimoto, Kozo
    Hoefsloot, Wouter
    Mange, Kevin C.
    Yuen, Dayton W.
    Ciesielska, Monika
    Wallace, Richard J., Jr.
    van Ingen, Jakko
    Brown-Elliott, Barbara A.
    Coulter, Chris
    Winthrop, Kevin L.
    CHEST, 2021, 160 (03) : 831 - 842
  • [26] Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease A NTM-NET study
    Zweijpfenning, Sanne Maria Henriette
    Chiron, Raphael
    Essink, Sharon
    Schildkraut, Jodie
    Akkerman, Onno W.
    Aliberti, Stefano
    Altenburg, Josje
    Arets, Bert
    van Braeckel, Eva
    Delaere, Benedicte
    Gohy, Sophie
    Haarman, Eric
    Lorent, Natalie
    McKew, Genevieve
    Morgan, Lucy
    Wagner, Dirk
    van Ingen, Jakko
    Hoefsloot, Wouter
    CHEST, 2022, 162 (01) : 76 - 81
  • [27] A Case of Single-lung Transplant in a Patient with Mycobacterium avium Pulmonary Disease Successfully Treated with Amikacin Liposome Inhalation Suspension
    Ozeki, Taichi
    Higo, Hisao
    Omori, Hiroki
    Mori, Shunta
    Tanaka, Shin
    Makimoto, Go
    Ninomiya, Kiichiro
    Taniguchi, Akihiko
    Fujii, Masanori
    Miyoshi, Kentaro
    Rai, Kammei
    Ichihara, Eiki
    Ohashi, Kadoaki
    Sugimoto, Seiichiro
    Hotta, Katsuyuki
    Tabata, Masahiro
    Toyooka, Shinichi
    Maeda, Yoshinobu
    Miyahara, Nobuaki
    INTERNAL MEDICINE, 2024,
  • [28] AN OPEN-LABEL EXTENSION STUDY OF AMIKACIN LIPOSOME INHALATION SUSPENSION (ALIS) FOR TREATMENT-REFRACTORY LUNG DISEASE CAUSED BY MYCOBACTERIUM AVIUM COMPLEX (MAC)
    Winthrop, Kevin
    Morimoto, Kozo
    Castellotti, Paola Francesca
    Yim, Jae-Joon
    Ruoss, Stephen
    van Ingen, Jakko
    Coulter, Christopher
    Mange, Kevin
    Nezamis, James
    Griffith, David
    CHEST, 2019, 156 (04) : 146A - 147A
  • [29] Management of dysphonia caused by amikacin liposome inhalation in M. avium complex pulmonary disease
    Kurahara, Y.
    Kanaoka, K.
    Tanaka, Y.
    Maeda, Y.
    Kobayashi, T.
    Takeuchi, N.
    Kagawa, T.
    Tachibana, K.
    Yoshida, S.
    Tsuyuguchi, K.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2023, 27 (11) : 872 - 873
  • [30] Laryngeal Injury Due to Amikacin Inhalation for Refractory Mycobacterium avium Complex Infection
    Axiotakis, Lucas G.
    Enver, Necati
    Keating, Claire L.
    Pitman, Michael J.
    CHEST, 2021, 159 (04) : E185 - E187